INMUNE BIO INC. - COMMON STOCK

INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neurosciences Conference

26 апр 2021 09:00:00 Источник Nasdaq GlobeNewswire

INmune Bio, Inc. Announces Professor Mark Lowdell, PhD, CSO to Deliver Presentations at Two Upcoming Medical Meetings

22 мар 2021 09:00:00 Источник Nasdaq GlobeNewswire

INmune Bio, Inc. Announces Participation at Upcoming Virtual Investor Conferences in March 2021

08 мар 2021 09:00:00 Источник Nasdaq GlobeNewswire

INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business Update

04 мар 2021 16:15:00 Источник Nasdaq GlobeNewswire

INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4

25 фев 2021 09:00:00 Источник Nasdaq GlobeNewswire

INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial

21 янв 2021 07:00:00 Источник Nasdaq GlobeNewswire

INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday, January 21 at 8 AM ET

13 янв 2021 08:00:00 Источник Nasdaq GlobeNewswire